New Hope Network is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Evolva hits big milestone in stevia project with Cargill

Evolva hits big milestone in stevia project with Cargill
Cargill will make a $1 million milestone payment to Evolva for achieving a technical milestone in their joint development of fermentation-based minor steviol glycosides.

Cargill and Evolva Holding SA (SIX: EVE) announced the achievement of a technical milestone in their joint development program of fermentation-based minor steviol glycosides—the compounds responsible for the sweet taste in the stevia leaf. The milestone is an enabling step in bringing additional great tasting stevia-based sweeteners to market in a cost effective and sustainable way for food and beverage manufacturers.

As a result of the achievement, Cargill will make a USD $1 million milestone payment to Evolva. Evolva is eligible for total milestone payments of up to USD $7.5 million during the R&D period.

In 2013, Cargill and Evolva entered into an agreement to jointly develop and commercialize fermentation-based minor steviol glycosides. Later in 2013 the companies announced that their program was moving into pilot-scale ahead of schedule.

David Henstrom, global business director for Health Ingredients at Cargill, commented, "We are encouraged by this project's trajectory. We look forward to offering cost-effective, great tasting, minor steviol glycosides in the market in the near future."

Neil Goldsmith, Evolva CEO, added, "The Cargill and Evolva teams are making excellent progress in a great spirit of cooperation. We are working hard to bring the project forward to the next important milestone."

Hide comments
account-default-image

Comments

  • Allowed HTML tags: <em> <strong> <blockquote> <br> <p>

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Publish